These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 21859392)
1. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells. Fedejko-Kap B; Niemira M; Radominska-Pandya A; Mazerska Z Xenobiotica; 2011 Dec; 41(12):1044-55. PubMed ID: 21859392 [TBL] [Abstract][Full Text] [Related]
2. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s. Potega A; Dabrowska E; Niemira M; Kot-Wasik A; Ronseaux S; Henderson CJ; Wolf CR; Mazerska Z Drug Metab Dispos; 2011 Aug; 39(8):1423-32. PubMed ID: 21555506 [TBL] [Abstract][Full Text] [Related]
3. Prochiral sulfoxidation as a probe for multiple forms of the microsomal flavin-containing monooxygenase: studies with rabbit FMO1, FMO2, FMO3, and FMO5 expressed in Escherichia coli. Rettie AE; Lawton MP; Sadeque AJ; Meier GP; Philpot RM Arch Biochem Biophys; 1994 Jun; 311(2):369-77. PubMed ID: 8203899 [TBL] [Abstract][Full Text] [Related]
4. Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10. Fedejko-Kap B; Bratton SM; Finel M; Radominska-Pandya A; Mazerska Z Drug Metab Dispos; 2012 Sep; 40(9):1736-43. PubMed ID: 22659092 [TBL] [Abstract][Full Text] [Related]
5. The metabolism of pyrazoloacridine (NSC 366140) by cytochromes p450 and flavin monooxygenase in human liver microsomes. Reid JM; Walker DL; Miller JK; Benson LM; Tomlinson AJ; Naylor S; Blajeski AL; LoRusso PM; Ames MM Clin Cancer Res; 2004 Feb; 10(4):1471-80. PubMed ID: 14977851 [TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of the metabolism of haloperidol using recombinant cytochrome p450 enzymes and human liver microsomes. Fang J; McKay G; Song J; Remillrd A; Li X; Midha K Drug Metab Dispos; 2001 Dec; 29(12):1638-43. PubMed ID: 11717183 [TBL] [Abstract][Full Text] [Related]
7. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans. Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531 [TBL] [Abstract][Full Text] [Related]
8. Roles of FMO and CYP450 in the metabolism in human liver microsomes of S-methyl-N,N-diethyldithiocarbamate, a disulfiram metabolite. Pike MG; Martin YN; Mays DC; Benson LM; Naylor S; Lipsky JJ Alcohol Clin Exp Res; 1999 Jul; 23(7):1173-9. PubMed ID: 10443982 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of a disulfiram metabolite, S-methyl N,N-diethyldithiocarbamate, by flavin monooxygenase in human renal microsomes. Pike MG; Mays DC; Macomber DW; Lipsky JJ Drug Metab Dispos; 2001 Feb; 29(2):127-32. PubMed ID: 11159801 [TBL] [Abstract][Full Text] [Related]
10. Identification of enzymes involved in the metabolism of atrazine, terbuthylazine, ametryne, and terbutryne in human liver microsomes. Lang DH; Rettie AE; Böcker RH Chem Res Toxicol; 1997 Sep; 10(9):1037-44. PubMed ID: 9305587 [TBL] [Abstract][Full Text] [Related]
11. Insulin in flavin-containing monooxygenase regulation. Flavin-containing monooxygenase and cytochrome P450 activities in experimental diabetes. Borbás T; Benko B; Dalmadi B; Szabó I; Tihanyi K Eur J Pharm Sci; 2006 May; 28(1-2):51-8. PubMed ID: 16488120 [TBL] [Abstract][Full Text] [Related]
12. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase. Kousba A; Soll R; Yee S; Martin M Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660 [TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. Lang DH; Rettie AE Br J Clin Pharmacol; 2000 Oct; 50(4):311-4. PubMed ID: 11012553 [TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism. Yu J; Brown DG; Burdette D Drug Metab Dispos; 2010 Oct; 38(10):1767-78. PubMed ID: 20595377 [TBL] [Abstract][Full Text] [Related]
15. CYP3A4-dependent cellular response does not relate to CYP3A4-catalysed metabolites of C-1748 and C-1305 acridine antitumor agents in HepG2 cells. Augustin E; Niemira M; Hołownia A; Mazerska Z Cell Biol Int; 2014 Nov; 38(11):1291-303. PubMed ID: 24890801 [TBL] [Abstract][Full Text] [Related]
16. Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Rawden HC; Kokwaro GO; Ward SA; Edwards G Br J Clin Pharmacol; 2000 Apr; 49(4):313-22. PubMed ID: 10759686 [TBL] [Abstract][Full Text] [Related]
17. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs. Yamazaki M; Shimizu M; Uno Y; Yamazaki H Biochem Pharmacol; 2014 Jul; 90(2):159-65. PubMed ID: 24821112 [TBL] [Abstract][Full Text] [Related]
18. Extrahepatic metabolism of carbamate and organophosphate thioether compounds by the flavin-containing monooxygenase and cytochrome P450 systems. Furnes B; Schlenk D Drug Metab Dispos; 2005 Feb; 33(2):214-8. PubMed ID: 15547051 [TBL] [Abstract][Full Text] [Related]
19. What is the contribution of human FMO3 in the N-oxygenation of selected therapeutic drugs and drugs of abuse? Wagmann L; Meyer MR; Maurer HH Toxicol Lett; 2016 Sep; 258():55-70. PubMed ID: 27320963 [TBL] [Abstract][Full Text] [Related]
20. Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin. Parte P; Kupfer D Drug Metab Dispos; 2005 Oct; 33(10):1446-52. PubMed ID: 15987777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]